...
首页> 外文期刊>Nuclear Medicine and Biology >Targeting of MMP2 activity in malignant tumors with a Ga-68-labeled gelatinase inhibitor cyclic peptide
【24h】

Targeting of MMP2 activity in malignant tumors with a Ga-68-labeled gelatinase inhibitor cyclic peptide

机译:Ga-68标记明胶酶抑制剂环肽靶向恶性肿瘤中MMP2活性

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Elevated levels of gelatinases (matrix metalloproteinases 2/9, i.e., MMP2 and MMP9) are associated with tumor progression, invasion and metastasis, so these enzymes are potential targets for tumor imaging. The peptide c(KAHWGFTLD)NH2 (herein, C6) is a selective gelatinase inhibitor. Cy5.5-C6 has been visualized in many tumor models in vivo. However, the sensitivity and penetrance of optical imaging are poor. It is well known that positron emission tomography (PET) has a high detection sensitivity and Gallium-68 (Ga-68) is an optimal PET radioisotope. Thus, in the present study, we developed a novel ligand, Ga-68-NOTA-C6, to image MMP2 activity in tumors.
机译:简介:明胶酶(基质金属蛋白酶2/9,即MMP2和MMP9)水平升高与肿瘤的进展,侵袭和转移有关,因此这些酶是肿瘤成像的潜在靶标。肽c(KAHWGFTLD)NH 2(在此为C6)是选择性明胶酶抑制剂。 Cy5.5-C6已在许多体内肿瘤模型中可视化。但是,光学成像的灵敏度和渗透率很差。众所周知,正电子发射断层扫描(PET)具有高检测灵敏度,而镓68(Ga-68)是最佳的PET放射性同位素。因此,在本研究中,我们开发了一种新型配体Ga-68-NOTA-C6来成像肿瘤中MMP2的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号